Implication of intracellular glutathione and its related enzymes on resistance of malaria parasites to the antimalarial drug arteether

Parasitology International

Volumn 60, Issue 1, 2011, Pages 97-100

  Chandra, Ramesh ^a   Tripathi, L M ^a   Saxena, J K ^a   Puri, S K ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Arteether resistance; Glutathione; Glutathione reductase; Glutathione S transferase; Plasmodium vinckei; Rodent malaria

Indexed keywords

ARTEETHER; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ARTICLE; CELL PROTECTION; COMPARATIVE STUDY; DETOXIFICATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PLASMODIUM VINCKEI; PRIORITY JOURNAL;

ANIMALS; ANTIMALARIALS; ARTEMISININS; DRUG RESISTANCE; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; MALARIA; MICE; PARASITIC SENSITIVITY TESTS; PLASMODIUM;

PLASMODIUM VINCKEI; RODENTIA;

EID: 78751582076     PISSN: 13835769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parint.2010.09.009     Document Type: Article

References (37)

1. Breman J.G., Egan A., Keusch G.T. The intolerable burden of malaria: a new look at the numbers. Am J Trop Med Hyg 2001, 64(1-2 Suppl). iv-vii.
2. Wongsrichanalai C., Pickard A.L., Wernsdorfer W.H., Meshnick S.R. Epidemiology of drug-resistant malaria. Lancet Infect Dis 2002, 2(4):209-218.
3. WHO: the use of ACT in order to 'provide effective treatment against malaria and to slow the spread of drug resistance' in a statement released on 20 February 2002.
4. Jambou R., Legrand E., Niang M., Khim N., Lim P., Valney B., et al. Resistance of Plasmodium falciparum field isolates to in vitro artemether and point mutation of SERCA-type PfATPase6. Lancet 2005, 366:1960-1963.
5. Ferreira I.D., Martinelli A., Rodrigues L.A., do Carmo E.L., do Rosário V.E., Póvoa M.M., et al. Plasmodium falciparum from Pará state (Brazil) shows satisfactory in vitro response to artemisinin derivatives and absence of the S769N mutation in the SERCA-type PfATPase6. Trop Med Int Health 2008, (2):199-207.
6. Dondorp A.M., Nosten F., Yi P., Das D., Phyo A.P., Tarning J., et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009, (5):455-467.
7. Chawira A.N., Warhurst D.C., Peters W. Qinghaosu resistance in rodent malaria. Trans R Soc Trop Med Hyg 1986, 80(3):477-480.
8. Peters W., Robinson B.L. The chemotherapy of rodent malaria. LVI. Studies on the development of resistance to natural and synthetic endoperoxides. Ann Trop Med Parasitol 1999, 93(4):325-329.
9. 2+ ATPase), tctp, mdr1, and cg10. Antimicrob Agents Chemother 2006, 50(2):480-489.
10. Walker D.J., Pitsch J.L., Peng M.M., Robinson B.L., Peters W., Bhisutthibhan J., et al. Mechanisms of artemisinin resistance in the rodent malaria pathogen Plasmodium yoelii. Antimicrob Agents Chemother 2000, 44(2):344-347.
11. Ferrer-Rodriguez I., Perez-Rosado J., Gervais G.W., Peters W., Robinson B.L., Serrano A.E. Plasmodium yoelii: identification and partial characterization of an MDR1 gene in an artemisinin-resistant line. J Parasitol 2004, 90(1):152-160.
12. Golenser J., Waknine J.H., Krugliak M., Hunt N.H., Grau G.E. Current perspectives on the mechanism of action of artemisinins. Int J Parasitol 2006, 36(14):1427-1441.
13. Krishna S., Uhlemann A.-C., Haynes R.K. Artemisinins: mechanisms of action and potential for resistance. Drug Resist Updat 2004, 7(4-5):233-244.
14. Eckstein-Ludwig U., Webb R.J., Van Goethem I.D., East J.M., Lee A.G., Kimura M., et al. Artemisinins target the SERCA of Plasmodium falciparum. Nature 2003, 424(6951):957-961.
15. Kimura M., Tanabe K., Krishna S., Tsuboi T., Saito-Ito A., Otani S., et al. Gametocyte-dominant expression of a novel P-type ATPase in Plasmodium yoelii. Mol Biochem Parasitol 1999, 104(2):331-336.
16. Touyz R.M. Reactive oxygen species as mediators of calcium signaling by angiotensin II: implications in vascular physiology and pathophysiology. Antioxid Redox Signal 2005, 7:1302-1314.
17. Puri S.K., Chandra R. Plasmodium vinckei: selection of a strain exhibiting stable resistance to arteether. Exp Parasitol 2006, 114(2):129-132.
18. McGonigle S., Dalton J.P., James E.R. Peroxidoxins: a new antioxidant family. Parasitol Today 1998, 14(4):139-145.
19. Baggaley V.C., Atkinson E.M. Use of CF 12 columns for preparations of DNA from rodent malarias. Trans R Soc Trop Med Hyg 1972, 66(1):4-5.
20. Siddiqui W.A., Kan S.C., Kramer K., Richmond-Crum S.M. In vitro production and partial purification of Plasmodium falciparum antigen. Bull World Health Organ 1979, 57(Suppl 1):75-82.
21. Brehe J.E., Burch H.B. Enzymatic assay for glutathione. Anal Biochem 1976, 74(1):189-197.
22. Nishikami M., Appaji R.N.-K. The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem Biophys Res Commun 1972, 46:849-854.
23. Racker E. Glutathione reductase (liver and yeast). Meth Enzymol 1955, 2:722-725.
24. Moss R.D., Board R.C., Gusalus I.C. The mechanism of the heterocyclic fermentation: a new rout of ethanol fermentation. J Bacterial 1951, 6:499-511.
25. Forstrom J.W., Zakowski J.J., Tappel A.L. Identification of the catalytic site of rat liver glutathione peroxidase as selenocysteine. Biochemistry 1978, 17:2639-2644.
26. Habig W.H., Pabst M.J., Jakoby W.B. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J Biol Chem 1974, 249:7130-7139.
27. Kakkar P., Das B., Viswanathan P.N. A modified spectrphotometric assay of superoxide dismutase. Indian J Biochem Biophys 1984, 21:130-132.
28. Ittarat W., Sreepian A., Srisarin A., Pathepchotivong K. Effect of dihydroartemisinin on the antioxidant capacity of P. falciparum-infected erythrocytes. Southeast Asian J Trop Med Public Health 2003, 34(4):744-750.
29. Wang D.-Y., Wu Y.-L. A possible antimalarial action mode of quighaosu (artemisinin) series compounds. Alkylation of reduced glutathione by C-centered primary radicals produced from antimalarial compound qinghaosu and 12-(2,4-dimethoxyphenyl)-12-deoxoqinghaosu. Chem Commun 2000, 2193-2194.
30. Meierjohann S., Walter R.D., Muller S. Regulation of intracellular glutathione levels in erythrocytes infected with chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. Biochem J 2002, 368(Pt 3):761-768.
31. Dubois V.L., Platel D.F., Pauly G., Tribouley-Duret J. Plasmodium berghei: implication of intracellular glutathione and its related enzyme in chloroquine resistance in vivo. Exp Parasitol 1995, 81(1):117-124.
32. He Z., Chen L., You J., Qin L., Chen X. Antiretroviral protease inhibitors potentiate chloroquine antimalarial activity in malaria parasites by regulating intracellular glutathione metabolism. Exp Parasitol 2009, 123:122-127.
33. Atamna H., Ginsburg H. Heme degradation in the presence of glutathione. A proposed mechanism to account for the high levels of non-heme iron found in the membranes of hemoglobinopathic red blood cells. J Biol Chem 1995, 270(42):24876-24883.
34. Ginsburg H., Famin O., Zhang J., Krugliak M. Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action. Biochem Pharmacol 1998, 56(10):1305-1313.
35. Mannervik B., Danielson U.H. Glutathione transferases - structure and catalytic activity. CRC Crit Rev Biochem 1988, (23):283-337.
36. Srivastava P., Puri S.K., Kamboj K.K., Pandey V.C. Glutathione-S transferase activity in malarial parasites. Trop Med Int Health 1999, 4:251-254.
37. Deponte M., Becker K. Glutathione S-transferase from malarial parasites - structural and functional aspects. Meth Enzymol 2005, (401):240-252.